Data Sheet 1_Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic NSCLC.docx

Data Sheet 1_Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic NSCLC.docx

Background<p>Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-based combination therapy modalities for patients with EGFR-mutated stage IV non-small cell lung cancer (NSCLC) are being investigated. We evaluated the value and safety of third-generation EGFR-TKIs combined...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Xinhang Gu (22686224) (author)
Andere auteurs: Jiaxiao Geng (22509188) (author), Hongfu Sun (10054227) (author), Qiang Cao (119096) (author), Yan Yi (504321) (author), Baosheng Li (290758) (author)
Gepubliceerd in: 2025
Onderwerpen:
Oncology and Carcinogenesis not elsewhere classified
non-small cell lung cancer
radiotherapy
epidermal growth factor receptor
tyrosine kinase inhibitor
radiation dosage
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items